|
1 |
1. Albrades J.G., Albillos A., Turnes J. et al. Hemodynamic effects and safety of one-month simvastatin treatment in patients with cirrhosis and portal hypertension. A double-blind randomized, placebo-controlled multicenter trial // J. Hepatol.-2008.- 48.- P. 25 A. 2. Batkai S., Jarai Z., Wagner J.A. et al. Endocannabinoids acting at vascular CBI receptors mediate the vasodilated state in advanced liver cirrhosis // Nat. Med.- 2001.- 7.- P. 827-832. 3. Cassiman D., Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic cell research //J. Hepatol.- 2002.- 37.- P. 527-535. 4. Domenicali M., Caraceni P., Pertosa A.M. et al. Effect of cannabinoid CBI-receptor antagonism on ascitic decompensation of rats with preascitic cirrhosis // J. Hepatol.- 2008.-48.- P. 88A. 5. Fernandez M., Mejias M., Garcia-Pras E. et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by сombined vascular endothelial growth factor and platelet derived growth factor and platelet-derived growth blockade in rats // Hepatology.- 2007.- 46.- P. 1208-1217. 6. Fiorucci S., Antonelli E., Brancaleone V. et al. NCX-1000, a nitric oxide-releasing derivate of ursodeoxycholic acid, ameliorates portal hypertension and lowers norephineprine induced intrahepatic resistance in the isolated and perfused rat liver // J. Hepatol.- 2003.- 39.- P. 932-939. 7. Garcia-Pagan J.C., Caca K., Bureau C. et al. An early decision for PTFE-tips improves survival in high risk cirrhotic patients admitted with an acute variceal bleeding. A multicenter RCT // J.Hepatol.- 2008.- 48.- P. 371 8. Gonzales-Albrades J., Albilos A., Banares R. et al. Randomized comparison of long-term losartan versus propanolol in lowering portal pressure in cirrhosis // Gastroenterology.-2001.- 121.- P. 382-388. 9. Groszmann R.J., Bosch J., Grace N.D. et al. Hemodynamic events in a prospective randomized trial of propanolol versus placebo in the prevention of a first variceal hemorrhage //Gastroenterology.- 1990.- 90.- P. 1401-1407. 10. Hernandez-Guerra M., Garcia-Pagan J.C., Turnes J. et al. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension //Hepatology.-2006.- 43.-P. 485-491. 11. Kasimov S. et al. haemosorption In Complex Management Of Hepatargia: o27 (l1-1) //The International Journal of Artificial Organs. – 2013. – Т. 36. – №. 8. – С. 548. 12. Kasymov S. Z., Davlatov S. S. Hemoperfusion as a method of homeostasis protection in multiple organ failure syndrome //ББК 51.1+ 74.58 Қ 22. – 2013. – С. 85. 13. Laleman W., Van Landeghem L., Van Der Elst I. et al. Nitroflurbiprofen, a Nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats //Gastroenterology.- 2007.- 132.- P. 709-719. |